[HTML][HTML] Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome

C Castaño-Amores, A Antúnez-Rodríguez… - Biomedicine & …, 2023 - Elsevier
Betablockers (BBs) are prescribed for ischaemia in patients with acute coronary syndrome
(ACS). In Spain, bisoprolol and carvedilol are the most prescribed BBs, but patients often …

Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome

C Castaño-Amores… - Biomedicine & … - pubmed.ncbi.nlm.nih.gov
Betablockers (BBs) are prescribed for ischaemia in patients with acute coronary syndrome
(ACS). In Spain, bisoprolol and carvedilol are the most prescribed BBs, but patients often …

[PDF][PDF] Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome

C Castano-Amores, A Antúnez-Rodríguez… - Biomedicine & …, 2023 - researchgate.net
Betablockers (BBs) are prescribed for ischaemia in patients with acute coronary syndrome
(ACS). In Spain, bisoprolol and carvedilol are the most prescribed BBs, but patients often …

Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.

C Castaño-Amores, A Antúnez-Rodríguez… - Biomedicine & …, 2023 - europepmc.org
Betablockers (BBs) are prescribed for ischaemia in patients with acute coronary syndrome
(ACS). In Spain, bisoprolol and carvedilol are the most prescribed BBs, but patients often …